- 03 Mar | First event
The European Cooperative Study Group for Pediatric Rare Tumors (EXPeRT) is composed of professionals that have dedicated their research activity to increase the scientific knowledge of pediatric very rare tumors and improve the treatment and care of children and adolescents that suffer from these tumors.
Very rare tumors in children are considered those having an incidence of less than 2 cases/million/year and not included in already defined international or national protocols (such as primary liver tumors and germ cell tumors). Some are rare at any age and some are often encountered in the adult population but are exceptional in children.
Univocal diagnostic/therapeutic criteria for these neoplasm do not exist. Moreover, because of their rarity, physicians have often less resources and in some cases less interest in understanding their natural history and developing clinical studies, as well as a biological research.
Additionally, the small number of cases cannot amortize the costs of a specific pharmacologic research and leads to a scarce diffusion of existing information and knowledge.
For all these reasons, rare tumors in pediatric age should be considered as “orphan” diseases.
Examples of very rare tumors in childhood cancer are the following:
This list is not exhaustive and needs to be continuously updated because newly discovered entities ought to be added.
This website arises from the project ExPO-r-Net, which has received funding from the European Union in the framework of the Health Programme (2008-2013), grant agreement nr. 2013 12 07. The content represents the views of the author and is his sole responsibility and it can in no way be taken to reflect the views of European Union bodies. The European Commission and/or Chafea do not accept responsibility for any use that may be made of the information it contains.